From: The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer
Group
n
CR
PR
MR
SD
PD
Response rate
P
Trial
69
1
12
11
27
18
13/69 (18.84%)
0.022
Control
36
0
4
19
1/36 (2.78%)